Filter posts

Licensing of Research Has Had Huge Impact on Economy & Jobs

A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately …

Setting the Record Straight on March-In Rights

In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

Senator Roberts is a Champion of Biotechnology Innovation

Last night, U.S. Senator Pat Roberts (R-Kan.) accepted BIO’s Lifetime Achievement Award, which recognized his …

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

Happy 91st Birthday Senator Bayh!

At its best, government enables citizens to flourish socially and economically. Above and beyond the …

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an …

Drug Importation: Dangerous for Patients, Consumers, and American Communities

Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a …

USMCA Paves the Way for Biotech Innovation

After more than a year of high-stakes drama, the U.S. has inked an updated trade …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …